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Objectives The aim of the present study was to compare the characteristics of nonculprit coronary
plaques between diabetes mellitus (DM) and non-DM patients using 3-vessel optical coherence to-
mography (OCT) imaging.
Background DM patients have a higher recurrent cardiovascular event rate.
Methods Patients who had undergone 3-vessel OCT imaging were identiﬁed from the Massachu-
setts General Hospital OCT Registry. Characteristics of nonculprit plaques were compared between
DM and non-DM patients.
Results A total of 230 nonculprit plaques were identiﬁed in 98 patients. Compared with non-DM
patients, DM patients had a larger lipid index (LI) (averaged lipid arc  lipid length; 778.6  596.1
vs. 1358.3  939.2, p  0.001) and higher prevalence of calciﬁcation (48.4% vs. 72.2%, p  0.034)
and thrombus (0% vs. 8.3%, p  0.047). DM patients were divided into 2 groups based on glycated
hemoglobin (A1C) levels of 7.9% and 8.0%. LI was signiﬁcantly correlated with diabetic status
778.6  596.1 [non-DM] vs. 1,171.5  708.1 [A1C 7.9%] vs. 1,638.5  1,173.8 [A1C 8%], p value
for linear trend  0.005), and ﬁbrous cap thickness was inversely correlated with the A1C level
(99.4  46.7 m [non-DM] vs. 91.7  29.6 m [A1C 7.9%] vs. 72.9  22.7 m [A1C 8%], p value
or linear trend  0.014). Patients with A1C 8% also had the highest prevalence of thin-cap ﬁbro-
atheroma (TCFA) and macrophage inﬁltration.
Conclusions Compared with non-DM patients, DM patients have a larger LI and a higher preva-
lence of calciﬁcation and thrombus. The LI was larger and TCFA and macrophage inﬁltration were
frequent in patients with A1C 8%. (J Am Coll Cardiol Intv 2012;5:1150–8) © 2012 by the
American College of Cardiology Foundation
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1151Diabetes mellitus (DM) is an independent risk factor for the
development of coronary heart disease (CHD) (1–3). DM
patients have been reported to have a 2- to 5-fold higher
incidence of myocardial infarction or death (4,5) and a
2-fold higher incidence of recurrent ischemic events during
a 7-year follow-up (45.0% vs. 20.2%) (4). The risk of
myocardial infarction or death in DM patients without
known CHD is as high as that in non-DM patients with
known CHD (4). DM patients have worse outcomes after
acute coronary syndrome (ACS) (6–8), percutaneous cor-
onary intervention (9,10), and surgical revascularization
(9,11). The underlying pathophysiology for the poor
outcomes and high recurrent ischemic events in DM
patients has not been fully elucidated. A postmortem study
showed that compared with non-DM patients, DM pa-
tients had plaques with larger necrotic cores and increased
macrophage infiltration, and that the size of the necrotic
core was correlated positively with the glycated hemoglobin
(A1C) level (12). Prospective studies have shown continuous
ssociations of blood glucose and A1C level with the risks of
major vascular events (13,14). A recent large-scale observa-
tional study reported that compared with subjects with
A1C 6% to 8%, patients with A1C8% had a 16% higher
isk of cardiac events over 3 years (15). In vivo coronary
laque characteristics in DM patients have not been well
stablished.
Optical coherence tomography (OCT) is a high-
esolution intravascular imaging modality that enables de-
ailed assessment of coronary plaque morphology. The aim
f the present study was to characterize the nonculprit
laques in DM patients using 3-vessel OCT imaging and
ompare them with those in non-DM patients.
ethods
Study population. From a total of 912 subjects who were
enrolled in the Massachusetts General Hospital (MGH)
OCT Registry between August 2010 and September 2011,
we identified 108 subjects (81 subjects from Harbin Medical
University, Harbin, China, and 27 subjects from Nara
Medical University, Nara, Japan) with 3-vessel OCT imag-
ing. The MGH OCT Registry is a multicenter registry of
consecutive patients who have undergone OCT, and in-
cludes 20 sites across 6 countries. Poor image quality or lack
of A1C information resulted in the exclusion of 10 subjects;
herefore, 98 subjects (90.7%) were included in the final
nalysis. Eighty-eight subjects (89.8%) were studied by the
3 system (M3 Cardiology Imaging System, LightLab
maging/St. Jude Medical, Westford, Massachusetts) and
0 subjects (10.2%) by the C7 OCT system (C7-XR OCT
ntravascular Imaging System, LightLab Imaging/St. Jude
edical, Westford, Massachusetts). A subject was assigned
o the DM group if the subject was receiving an oral
ypoglycemic agent or insulin, or if the subject had a known vasting blood glucose value of 126 mg/dl or post-prandial
-h blood glucose value of 200 mg/dl. Nonculprit lesions
ere defined as plaques viewed on an angiogram that had
ot been treated. Within the nonculprit lesions, only
laques with more than 30% diameter stenosis as compared
ith the reference diameter as measured by OCT were
ncluded in our study. Plaque characteristics were compared
etween DM subjects and non-DM subjects. Moreover,
M subjects were divided into 2 groups based on A1C level
of 7.9% or 8%, and plaque characteristics were com-
pared. Each plaque was separated at least 5 mm from the
edge of another plaque or an implanted stent edge. The
Registry was approved by each site’s institutional review
board, and all patients provided informed consent.
Acquisition of OCT images. Images were acquired using
commercially available, time-domain (M3 Cardiology Im-
aging System) or frequency-
domain (C7-XR OCT Intravas-
cular Imaging System) OCT
systems. The intracoronary OCT
imaging technique has been de-
scribed previously (16–18). In brief,
the M3 system uses an occlusion
balloon (Helios, LightLab Imag-
ing) that is inflated proximal to the
lesion at 0.4 to 0.6 atm during
image acquisition. The imaging
wire is automatically pulled back
from a distal to a proximal position
at a rate of 1.0 to 3.0 mm/s, and
saline is continuously infused from
the tip of the occlusion balloon. In
the C7 system, a 2.7-F OCT im-
aging catheter (Dragonfly, Light-
Lab Imaging) is advanced distal to
the lesion, and automated pullback
is initiated in concordance with
blood clearance by the injection of
contrast media or dextran. All images were de-identified and
digitally stored.
OCT data analysis. Plaques were classified into 2 categories
16,19–22): 1) fibrous (homogeneous, highly backscattering
egion) or 2) lipid (low signal region with diffuse border).
hen lipid was present 90° in any of the cross-sectional
mages within the plaque, it was considered as a lipid-rich
laque. In lipid-rich plaque, the lipid arc was measured at
very 1-mm interval throughout the length of each lesion,
nd the values were averaged. Lipid length was also
easured on longitudinal view. Lipid index (LI) was
efined as the mean lipid arc multiplied by lipid length.
he fibrous cap thickness of a lipid-rich plaque was
easured 3 times at its thinnest part, and the average
Abbreviations
and Acronyms
A1C  glycated hemoglobin
ACS  acute coronary
syndrome
CHD  coronary heart
disease
DM  diabetes mellitus
HDL  high-density
lipoprotein
LI  lipid index
MGH  Massachusetts
General Hospital
OCT  optical coherence
tomography
TCFA  thin-cap
fibroatheroma
VH-IVUS  virtual histology–
intravascular ultrasoundalue was calculated. Thin-cap fibroatheroma (TCFA)
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1152was defined as the thinnest fibrous cap thickness of 65
m in a lipid-rich plaque on a cross-sectional image.
acrophage infiltration was defined as signal-rich, dis-
inct or confluent punctuate regions that exceed the
ntensity of background speckle noise (23–25). Micro-
hannels were defined as signal-poor voids that were
harply delineated in multiple contiguous frames (25,26).
laque disruption was identified by the presence of
brous cap discontinuity with a clear cavity formation
nside the plaque (19). Intracoronary thrombus was
efined as a mass (diameter 250 m) attached to the
uminal surface or floating within the lumen, including
ed (red blood cell–rich) thrombus, which showed high
ackscattering with high attenuation (resembling blood),
nd white (platelet-rich) thrombus, which showed less
ackscattering, was homogeneous, and had low attenua-
ion (19,25,27). Calcification was also recorded when an
rea consisted of a signal-poor or heterogeneous region
ith a sharply delineated border (25). Macrophage infil-
ration, microchannel, plaque disruption, thrombus, and
alcification were recorded only for their presence. The
CT data were analyzed at an independent MGH OCT
ore laboratory by 2 experienced investigators who were
linded to the angiographic and clinical findings, using pro-
rietary software (LightLab Imaging). When there was dis-
ordance between the investigators, a consensus reading was
btained from a third independent reviewer. Intraclass
orrelation coefficient for inter- and intraobserver reliabili-
ies of the lipid arc were 0.844 and 0.903, respectively.
Statistical analysis. All statistical analyses were performed
y an independent statistician. For analysis of patient
haracteristics, categorical data were compared using the
hi-square test or Fisher exact test, depending on which
est was most suitable; these data are presented as
requencies (percent). Continuous measurements are pre-
ented as mean  SD and median (25th to 75th percentile).
The means of the continuous measurements in the 2
groups were compared using the Student’s t test. Throm-
bus analysis was carried out using the Fisher exact test
because of the infrequency of the events. Linear regres-
sion analysis was used to analyze the relationship between
the OCT plaque measurement and A1C level. For com-
parisons of plaque characteristics between the groups, the
analysis was carried out using the generalized estimating
equations approach to account for the within-subject
correlation due to the analysis of multiple plaques within
a single patient. Intra-observer and interobserver reliabili-
ties were estimated by the intraclass correlation coefficient
for continuous measurement. All analyses were performed
using SAS version 9.1.3 (SAS Institute, Cary, North Car-
olina). Values of p  0.05 were considered statistically
significant.Results
Baseline characteristics. Baseline patient characteristics are
hown in Table 1. The non-DM group consisted of 62
ubjects, and the DM group 36 subjects. No significant
ifferences were observed in the baseline characteristics be-
ween the 2 groups, except for a higher frequency of smoking
nd a higher level of high-density lipoprotein (HDL) choles-
erol in the non-DM group. In the total population, 85.7%
atients underwent percutaneous coronary intervention at in-
ex procedure (85.5% of non-DM patients, 86.1% of DM
atients, p  0.999). Procedure-related complications with
espect to 3-vessel imaging were not reported from any
nstitution. The DM patients consisted of 23 subjects with
1C 7.9% and 13 subjects with A1C 8.0%. In the A1C
7.9% group, 13 subjects (56.5%) were receiving insulin
therapy, 4 subjects (17.4%) were on oral agents, and 6 subjects
(26.0%) were on no medicine. In the A1C 8.0% group, 11
ubjects (84.6%) were receiving insulin therapy, and 2 subjects
15.9%) were on no medical therapy.
Angiographic ﬁndings. A total of 230 nonculprit plaques were
detected in 98 subjects: 145 plaques in 62 non-DM subjects
(2.3 1.0 plaques/patient) and 85 plaques in 36 DM subjects
2.4  1.3 plaques/patient) (Table 2). The distribution of
laques in the 3 coronary arteries was as follows: 43.5% of
laques were located in the right coronary artery, 34.3% in the
eft anterior descending artery, and 22.2% in the left circum-
Table 1. Baseline Patient Characteristics
Non-DM
(n  62)
DM
(n  36) p Value
Age, yrs 59.6 9.5 58.0 11.3 0.465
Male 47 (75.8%) 24 (66.7%) 0.356
Hypertension 34 (54.8%) 27 (75.0%) 0.054
Hyperlipidemia 51 (82.3%) 29 (80.6%) 0.999
Smoking 41 (66.1%) 15 (41.7%) 0.021*
Current 15 (24.2%) 9 (25.0%) 0.999
Former (quit 3 months) 26 (41.9%) 6 (16.7%) 0.014*
ACS 10 (16.1%) 6 (16.7%) 0.999
STEMI 3 (4.8%) 4 (11.1%) 0.450
Non-STEMI/UA 7 (11.3%) 2 (5.6%) 0.559
Prior myocardial infarction 22 (35.5%) 12 (33.3%) 0.999
Peripheral artery disease 3 (4.8%) 1 (2.8%) 0.999
Chronic kidney disease 6 (9.7%) 4 (11.1%) 0.999
Fasting glucose 100.3 14.2 145.2 62.0 0.001*
A1C, % 5.5 0.8 7.4 1.3 0.001*
LDL-C, mg/dl 84.7 25.2 83.9 30.8 0.886
HDL-C, mg/dl 44.1 12.7 39.6 5.0 0.017*
Triglyceride, mg/dl 145.7 111.8 138.4 56.5 0.719
hs-CRP, mg/dl 0.21 0.40 0.25 0.18 0.570
Values are mean SD or n (%). *p 0.05.
ACS  acute coronary syndrome; A1C  glycated hemoglobin; DM  diabetes mellitus;
LDL-C  low-density lipoprotein cholesterol; HDL-C  high-density lipoprotein cholesterol;
hs-CRP  high-sensitivity C-reactive protein; STEMI  ST-segment elevation myocardial infarc-tion; UA unstable angina.
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1153flex; 42.2% of plaques were located in proximal lesions and
57.8% of plaques were in mid to distal lesions. This distribu-
tion was not different between the 2 groups.
OCT ﬁndings. The prevalence of OCT plaque characteris-
tics per patient and per plaque are shown in Table 2. The
prevalence of lipid-rich plaques was similar between
non-DM and DM subjects (67.7% vs. 63.9%, p  0.825),
nd the number of lipid-rich plaques per patient was also
imilar between the groups (1.2  1.1/patient vs. 1.3 
.4/patient, p  0.825). The prevalence of TCFA (19.4%
non-DM] vs. 27.8% [DM], p  0.277), macrophage
nfiltration (41.9% [non-DM] vs. 47.2% [DM], p 0.675),
isruption (14.5% [non-DM] vs. 16.7% [DM], p  0.778),
nd microchannels (56.5% [non-DM] vs. 52.8% [DM], p
.834) were not different between the groups. DM subjects
ad higher frequencies of calcification (48.4% [non-DM]
s. 72.2% [DM], p  0.034) and thrombus (0.0% [non-
M] vs. 8.3% [DM], p  0.047).
Comparisons of quantitative OCT findings between
on-DM and DM plaques are shown in Figure 1. Com-
ared with plaques of non-DM subjects, those of DM
ubjects had a wider lipid arc (114.5° 35.5°, 106.2 [87.5 to
33.9] vs. 136.3°  32.3°, 140.1 [111.1 to 162.3], p 
Table 2. Plaque Characteristics in Nonculprit Lesion
Patients (n  98)
Non-DM
(n  62)
DM
(n 
Plaques (per patient), n 145 (2.3 1.0) 85 (2.4
Lipid-rich plaques 42 (67.7%) 23 (63.9
Lipid-rich plaques/patient 1.2 1.1 1.3
TCFA 12 (19.4%) 10 (27.8
Macrophage inﬁltration 26 (41.9%) 17 (47.2
Disruption 9 (14.5%) 6 (16.7
Microchannel 35 (56.5%) 19 (52.8
Calciﬁcation 30 (48.4%) 26 (72.2
Thrombus 0 (0.0%) 3 (8.3%
Plaque location
RCA
Proximal
Mid
Distal
LAD
Proximal
Mid
Distal
LCX
Proximal
Distal
Values are n (mean SD), n (%), or mean SD. *p 0.05.
DM  diabetes mellitus; LAD  left anterior descending artery;
fibroatheroma..001), a longer lipid length (6.7  3.8 mm, 5.6 [4.1 to 8.1]s. 9.5  5.1 mm, 8.9 [5.4 to 11.9], p  0.001), and a
reater LI (778.6  596.1, 629.1 [381.3 to 1,089.2] vs.
,358.3  939.2, 1,225.7 [650.5 to 1,627.5], p 0.001).
owever, although the fibrous cap thickness tended to be
hinner in plaques of DM subjects, this difference was not
ignificant (99.4  46.7 m, 80.0 [70.0 to 117.8] [non-DM]
s. 84.2  28.3 m, 70.0 [61.5 to 105.0] [DM], p  0.076).
The correlations between the quantitative OCT findings
and A1C level are shown in Figure 2. The lipid arc (114.4 
5.5°, 106.2 [87.5 to 133.9] [non-DM] vs. 127.3  32.5°,
129.9 [94.9 to 147.7] [A1C7.9%] vs. 149.9 27.5°, 146.1
123.6 to 174.7] [A1C 8%], p value for linear trend
0.001), lipid length (6.7  3.8 mm, 5.6 [4.1 to 8.1]
non-DM] vs. 8.9  4.4 mm, 8.9 [4.9 to 11.1] [A1C
7.9%] vs. 10.4  6.0 mm, 9.0 [5.6 to 13.8] [A1C 8%],
p value for linear trend  0.011), and LI (778.6  596.1,
629.1 [381.3 to 1,089.2] [non-DM] vs. 1,171.5  708.1,
1,210.4 [619.6 to 1,522.9] [A1C 7.9%] vs. 1,638.5 
1,173.8, 1,368.2 [670.0 to 2,202.6] [A1C 8%], p value for
inear trend  0.005) were significantly correlated with A1C
level. The fibrous cap thickness was inversely correlated with
A1C level (99.4 46.7 m, 80.0 [70.0 to 117.8] [non-DM]
Patient and per Plaque
Plaques (n  230)
p Value
Non-DM
(n  145)
DM
(n  85) p Value
0.925
0.825 74 (51.0%) 45 (52.9%) 0.826
0.825
0.277 16 (11.0%) 16 (18.8%) 0.218
0.675 41 (28.3%) 26 (30.6%) 0.759
0.778 13 (9.0%) 6 (7.1%) 0.620
0.834 49 (33.8%) 28 (32.9%) 0.902
0.034* 48 (33.1%) 39 (45.9%) 0.111
0.047* 0 (0.0%) 3 (3.5%) 0.049*
0.922
20 (13.8%) 16 (18.9%)
21 (14.5%) 14 (16.5%)
20 (13.8%) 9 (10.6%)
15 (10.3%) 10 (11.8%)
22 (15.2%) 9 (10.6%)
15 (10.3%) 8 (9.4%)
22 (15.2%) 14 (16.5%)
10 (6.9%) 5 (5.9%)
left circumflex artery; RCA  right coronary artery; TCFA  thin-caps per
36)
 1.3)
%)
 1.4
%)
%)
%)
%)
%)
)
LCX vs. 91.7  29.6 m, 80.0 [70.0 to 120.0] [A1C 7.9%],
n
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115472.9 22.7 m, 61.5 [60.0 to 81.8] [A1C8%], p value for
linear trend  0.014).
Comparison of plaque characteristics among non-DM
patients, patients with A1C 7.9%, and those with A1C
8% are shown in Table 3. Compared with plaques of
on-DM subjects and those with A1C 7.9%, those with
1C 8% had higher prevalence of TCFA (11.0% [non-
M] and 8.9% [A1C 7.9%] vs. 37.9% [A1C 8%]; p 
.043 vs. A1C 7.9%, and p  0.037 vs. non-DM) and
acrophage infiltration (28.3% [non-DM] and 21.4% [A1C
7.9%] vs. 48.3% [A1C 8%], p  0.024 vs. A1C 7.9%,
and p 0.042 vs. non-DM), and thinner fibrous cap thickness
(p  0.035 vs. A1C 7.9%, p  0.004 vs. non-DM).
When all subjects were divided into a normal-HDL
roup or low-HDL group based on a cutoff HDL choles-
erol level of 40 mg/dl for men and 50 mg/dl for women (28),
here was no significant difference in the plaque characteristics
etween the 2 groups (lipid arc: 117.4  3.7°, 103 [92 to
38.5] [normal-HDL] vs. 123.6  36.2°, 115.3 [95.1 to
50.2] [low-HDL], p  0.495; lipid length: 6.6  4.3 mm,
.1 [3.7 to 8.4] [normal-HDL] vs. 8.0  4.5 mm, 6.9 [4.3
o 10.8] [low-HDL], p  0.233; LI: 845.4  709.9, 573.1
366.8 to 1,245.6] [normal-HDL] vs. 1,020.2  804.0,
94.7 [473.3 to 1,355.9] [low-HDL], p  0.389; fibrous
ap thickness: 94.5  43.4, 80.0 [77.5 to 92.5] [normal-
DL] vs. 88.9  26.1, 80.0 [63.0 to 110.0] [low-HDL],
 0.598).
iscussion
The present study demonstrated that nonculprit plaques in
Non-DM
200 20 3000 200
º μmmm p=0.076
DM
p=0.001 p=0.001 p<0.001
150 15
2000
150
100 10
1000
100
50 5 50
0 0 0 0
Lipid arc Lipid length Lipid Index Fibrous cap 
thickness
Figure 1. Comparison of OCT Quantitative Findings Between
Non-DM and DM Plaques
Nonculprit plaques of diabetes mellitus (DM) patients had a wider lipid arc
(p  0.001), a longer lipid length (p  0.001), and a greater lipid index
(p  0.001). Fibrous cap thickness tended to be thinner in plaques of DM
patients; however, this difference was not signiﬁcant (p  0.076). OCT 
optical coherence tomography.patients with DM had a wider lipid arc, a longer lipid alength, a larger LI, and a higher prevalence of calcification
and thrombus. When DM patients were further divided
into 2 groups based on A1C level, the nonculprit plaques in
atients with an A1C 8% had a higher prevalence of
CFA and macrophage infiltration, and thinner fibrous
ap.
Plaque characteristics in DM and non-DM patients. In a
postmortem study, coronary plaques in DM patients were
associated with larger necrotic core size and more diffuse
atherosclerosis with inflammatory cell infiltrates, such as
macrophage and T lymphocytes (12). Moreover, a positive
correlation was found between mean percent necrotic core
size and the A1C level (12). A directional coronary atherec-
tomy study by Moreno et al. (29) also showed that coronary
tissue from DM patients exhibited a larger content of
lipid-rich atheroma, macrophage infiltration, and thrombus
than did coronary tissue from non-DM patients. In the
present study, nonculprit plaques of DM patients had a
wider lipid arc, a longer lipid length, and a larger LI than
those of non-DM patients, and this feature was correlated
with DM status. It has been reported that nonculprit lesions
that lead to major adverse cardiovascular events are fre-
quently observed as mild stenotic lesions on angiogram;
however, the majority of events arose from plaques charac-
terized by a large plaque burden, a small luminal area, or
both, on gray-scale intravascular ultrasound (30). The prev-
alence of lipid-rich plaque was not different between the
non-DM and DM groups (67.7% vs. 63.9%, respectively,
p 0.825). The subanalysis of the PROSPECT (Providing
egional Observations to Study Predictors of Events in the
oronary Tree) study demonstrated the presence of any
broatheroma detected by virtual histology–intravascular
ltrasound (VH-IVUS) was not different between non-DM
nd DM groups; however, average necrotic core cross-
ectional area was significantly greater in the nonculprit
esions of DM patients with a future major adverse cardiac
vent (31).
Macrophage inﬁltration and TCFA. Previous pathological
tudies have reported that the level of inflammatory cell
nfiltration is higher in DM patients than in non-DM
atients (12,29). Moreover, an increased number of macro-
hages was related to necrotic core expansion, fibrous cap
hinning, and plaque instability (12). In the present study,
lthough the prevalence of macrophage infiltration did not
iffer between DM and non-DM patients, the patients with
n A1C 8% had a higher prevalence of macrophage
nfiltration compared with non-DM and A1C 7.9% pa-
ients. This finding suggests that poorly controlled DM
atients had a higher level of vulnerability in their coronary
laques compared with non-DM patients or relatively
ell-controlled DM patients.
TCFA is the precursor to plaque rupture, which accounts
or the majority of ACS and sudden cardiac death (32). In
VH-IVUS study, Hong et al. (33) demonstrated that
ha
l
l
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1155compared with non-DM patients, DM patients with ACS
had culprit lesions with a greater necrotic core volume and
higher prevalence of TCFA. A 3-vessel VH-IVUS study by
Zheng et al. (34) also showed that DM patients had a larger
necrotic core volume and more frequent TCFA than those
of non-DM patients. In the present study, the prevalence of
TCFA was not significantly different between non-DM and
DM patients; however, compared with non-DM patients
and patients with A1C 7.9%, those with A1C 8% had a
igher prevalence of TCFA.
Plaque characteristics in the poorly controlled DM group
(A1C >8%). Prospective studies have shown continuous
ssociations of blood glucose and A1C levels with the risk of
major vascular events (13,14). A recent large-scale observa-
tional study reported that compared with patients with A1C
of 6% to 8%, patients with A1C 8% had a 16% higher risk
of cardiac events over 3 years (15). In the present study,
patients with A1C 8% had a wider lipid arc, a longer lipid
ength, a larger LI, thinner fibrous caps, and higher preva-
ence of TCFA and macrophage infiltration, all of which
oincide with the typical pathological features of vulnerable
laque (32). Therefore, our data suggest that the patients
ith poorly controlled DM had more vulnerable plaques in
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Figure 2. Correlation Between Quantitative Findings of OCT and A1C Level
The lipid arc (p  0.001), lipid length (p  0.011), and LI (p  0.005) were sig
related with the A1C level (p  0.014). A1C  glycated hemoglobin; other abbhe nonculprit coronary lesions.Calciﬁcation. Calcification is another characteristic of DM
patients. VH-IVUS studies have shown that DM patients
have a greater amount of dense calcium than those of
non-DM patients in both culprit and nonculprit lesions
(35,36). Furthermore, an OCT study demonstrated that the
incidence of calcification is higher in DM patients (37). The
use of electron beam computed tomography for the detec-
tion of coronary artery calcium demonstrated that the extent
of coronary artery calcium strongly correlates with the
severity of coronary stenosis (38) and the development of
subsequent coronary events (39). Moreover, the presence of
coronary artery calcium in DM patients indicates a higher
risk for all-cause mortality than that in non-DM patients
(40). A postmortem study also showed that the mean
percent calcified area was greater in DM patients than in
non-DM patients (12). Our finding that DM patients have
a higher prevalence of calcification is in accordance with
previous findings reported by studies using VH-IVUS,
electron beam computed tomography, and pathological
examination.
Diabetes is not a local, but rather a systemic, disease.
Physiological studies reported that hyperglycemia, excess
free fatty acid, and insulin resistance in diabetes cause
30
25
Lipid lengthm
p = 0.011
20
15
10
5
0
00
Non-DM A1C≤7.9% A1C≥8%
Fibrous cap thicknessμm
50
00
p = 0.014
50
00
50
65
0
Non-DM A1C≤7.9% A1C≥8%
tly correlated with the A1C level. The ﬁbrous cap thickness was inversely cor-
ons as in Figure 1.m
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1156activation of these systems impairs endothelial function,
augments vasoconstriction, increases inflammation, and
promotes thrombosis (41). Inflammation has been increas-
ingly recognized as a component of atherogenesis. The
levels of C-reactive protein and fibrinogen have been found
to predict acute cardiovascular events in prospective studies
(42); however, in the present study, the level of high-
sensitivity C-reactive protein was not different between the
groups. Further investigation of biochemical findings re-
lated to prediction of adverse cardiac events would be
warranted.
In the present study, diabetic treatment type was not
different between the A1C 7.9% group and the A1C
8.0% group: 56.5% of the patients in the A1C 7.9%
roup and 84.6% in the A1C 8.0% group were receiving
insulin therapy. The duration of DM might affect the
plaque characteristics. However, the data on duration of
DM were not collected in the registry.
It has been reported in pathology (43) and OCT studies
(21) that plaques are not evenly distributed along the length
of the arteries. In the present study, 89.8% patients were
imaged by the M3 system, which requires an occlusion
balloon that is inflated proximal to the lesion. Therefore,
plaques in the ostium of the coronary arteries could not be
evaluated. Nevertheless, 42.2% plaques were located in
proximal segments and 57.8% plaques were in mid to distal
segments (Table 2).
Study limitations. First, this was a retrospective study using
a registry database. Therefore, potential selection bias is
unavoidable. Patients with cardiogenic shock, congestive
heart failure, chronic total occlusion, left main disease, or
Table 3. Comparison of Plaque Characteristics Among Non-DM Patients, P
Non-DM
(n  62)
A1C <7.9%
(n  23)
Total number of plaques 145 56
Lipid-rich plaques 74 (51.0%) 27 (48.2%)
TCFA 16 (11.0%) 5 (8.9%)
Macrophage inﬁltration 41 (28.3%) 12 (21.4%)
Disruption 13 (9.0%) 5 (8.9%)
Microchannel 49 (33.8%) 17 (30.4%)
Calciﬁcation 48 (33.1%) 25 (44.6%)
Thrombus 0 (0.0%) 2 (3.6%)
Lipid arc° 114.4 35.5 127.3 32.5
Median (IQR) 106.2 (87.5–133.9) 129.9 (94.9–147.7)
Lipid length, mm 6.7 3.8 8.9 4.4
Median (IQR) 5.6 (4.1–8.1) 8.9 (4.9–11.1)
Lipid index 778.6 596.1 1,171.5 708.1
Median (IQR) 629.1 (381.3–1,089.2) 1,210.4 (619.6–1,522.9)
FCT, m 99.4 46.7 91.7 29.6
Median (IQR) 80.0 (70.0–117.8) 80.0 (70.0–120.0)
Values are n (%), mean SD, or median (interquartile range [IQR]). Lipid index averaged lipid ar
ACS acute coronary syndrome; DM diabetes mellitus; FCT fibrous cap thickness; TCFA trenal failure were less likely to have 3-vessel OCT imagingperformed. Second, the exact measurements of necrotic core
and plaque burden by OCT were not possible because of the
relatively shallow axial penetration. However, because the
most important morphological determinants of plaque vul-
nerability are superficial, the region of greatest interest was
still within the imaging range of current OCT systems.
Third, disruption, microchannel, macrophage infiltration,
thrombus, and calcification were not quantified or rigor-
ously validated. Fourth, the use of 3-vessel OCT imaging
resulted in a limited sample size. The number of ACS
patients was small because performing 3-vessel OCT im-
aging in patients with hemodynamic instability is practically
difficult and unethical. Fifth, although OCT imaging was
performed in 3 vessels, most imaged segments did not
include the distal segments or, occasionally, the very prox-
imal segment. Sixth, although HDL cholesterol levels were
higher in the non-DM group compared with the DM
group, there were no differences in the plaque characteristics
between the 2 groups. Seventh, the duration of DM and the
time from onset of ACS to OCT were not collected in the
registry. Finally, we collected data on all patients with
3-vessel imaging in our registry, rather than sampling a
study sample based on a power analysis.
Conclusions
Plaques in DM patients have a wider lipid arc, a longer lipid
length, a larger LI, and a higher prevalence of calcification
and thrombus. Moreover, plaques of patients with poorly
controlled DM contained more vulnerable features. Further
studies are warranted to aid in understanding the clinical
s With A1C <7.9% and Those With A1C >8%
A1C >8%
(n  13)
Non-DM vs.
A1C <7.9%
A1C <7.9% vs.
A1C >8%
Non-DM vs.
A1C >8%
29
18 (62.1%) 0.783 0.326 0.351
11 (37.9%) 0.770 0.043* 0.037*
14 (48.3%) 0.436 0.024* 0.042*
1 (3.4%) 0.994 0.347 0.326
11 (37.9%) 0.658 0.495 0.687
14 (48.3%) 0.210 0.767 0.157
1 (3.4%) 0.077† 1.000† 0.167†
149.9 27.5 0.176 0.038* 0.001*
146.1 (123.6–174.7)
10.4 6.0 0.039* 0.448 0.033*
9.0 (5.6–13.8)
1638.5 1173.8 0.042* 0.231 0.016*
,368.2 (670.0–2,202.6)
72.9 22.7 0.415 0.035* 0.004*
61.5 (60.0–81.8)
length. *p 0.05. †Data were analyzed by Fisher exact test.
fibroatheroma.atient
1
c lipidimpact of the present findings and whether these are
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1157associated with higher event rates in poorly controlled
diabetic patients.
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